Blackmores Ltd
ASX:BKL
Intrinsic Value
Blackmores Ltd. engages in the business of development and marketing of health products for humans and animals. [ Read More ]
The intrinsic value of one BKL stock under the Base Case scenario is 81.65 AUD. Compared to the current market price of 94.73 AUD, Blackmores Ltd is Overvalued by 14%.
Valuation Backtest
Blackmores Ltd
Run backtest to discover the historical profit from buying and selling BKL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Blackmores Ltd
Current Assets | 384m |
Cash & Short-Term Investments | 75.1m |
Receivables | 120.9m |
Other Current Assets | 188m |
Non-Current Assets | 213.8m |
PP&E | 129.4m |
Intangibles | 65.1m |
Other Non-Current Assets | 19.4m |
Current Liabilities | 147.1m |
Accounts Payable | 105.2m |
Other Current Liabilities | 41.9m |
Non-Current Liabilities | 31.5m |
Long-Term Debt | 14.1m |
Other Non-Current Liabilities | 17.5m |
Earnings Waterfall
Blackmores Ltd
Revenue
|
641.5m
AUD
|
Cost of Revenue
|
-239.1m
AUD
|
Gross Profit
|
402.4m
AUD
|
Operating Expenses
|
-347.8m
AUD
|
Operating Income
|
54.6m
AUD
|
Other Expenses
|
-20m
AUD
|
Net Income
|
34.6m
AUD
|
Free Cash Flow Analysis
Blackmores Ltd
What is Free Cash Flow?
BKL Profitability Score
Profitability Due Diligence
Blackmores Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Blackmores Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
BKL Solvency Score
Solvency Due Diligence
Blackmores Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Blackmores Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BKL Price Targets Summary
Blackmores Ltd
According to Wall Street analysts, the average 1-year price target for BKL is 74.78 AUD .
Shareholder Return
BKL Price
Blackmores Ltd
Average Annual Return | 2% |
Standard Deviation of Annual Returns | 18.29% |
Max Drawdown | -38% |
Market Capitalization | 1.8B AUD |
Shares Outstanding | 19 448 500 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Blackmores Ltd. engages in the business of development and marketing of health products for humans and animals. The company is headquartered in Sydney, New South Wales and currently employs 1,200 full-time employees. The firm is engaged in developing, manufacturing, sales, and marketing of natural health products for humans and animals including vitamins, and herbal and mineral nutritional supplements. The firm's segments include Australia and New Zealand (ANZ), China, International. ANZ segment includes BioCeuticals and PAW brands sold across Australia and New Zealand. China segment consists of Blackmores and PAW by Blackmores brands in China and China Export Division. The International segment comprises of Indonesia, Thailand, Malaysia, Singapore, Hong Kong (China), Taiwan (China), Korea, Vietnam, Pakistan, and Kazakhstan.
Contact
IPO
Employees
Officers
The intrinsic value of one BKL stock under the Base Case scenario is 81.65 AUD.
Compared to the current market price of 94.73 AUD, Blackmores Ltd is Overvalued by 14%.